Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Acceptability clinical trials

3 of 5 indexed Acceptability trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Acceptability: 5 US clinical trials tracked, 3 recruiting.

Acceptability is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is University of California, Berkeley, running 2 of these trials.

Enrollment posture brief

Registry condition acceptability

OPEN 3 | RECR 60% | LATE 0 | EARLY 0 | RANK #3391 | SPON 2

Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability (this)60%Acral Lentiginous Melanoma20%
Open-enrollment share among volume-matched conditions near Acceptability

Acceptability lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Acceptability on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Acceptability is recruiting above its size-band peers.

    3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Acceptability research.

    University of California, Berkeley accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Acceptability trials plan to enrol fewer than 100 people.

    Median target enrolment is 40 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.

  4. Acceptability research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Acceptability records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Moringa Powder - High Dose Other
1 trials
Moringa Powder - Medium Dose Other
1 trials
Moringa Powder - Low Dose Other
1 trials
Fitted Transdiagnostic Sleep and Circadian intervention Behavioral
1 trials
Scheduling app Other
1 trials
Engaging Families home practice app Behavioral
1 trials
Mindfulness Smartphone Application Other
1 trials
Herbs and Spices Nutrition Education Program Behavioral
1 trials

US sites by state

Facility locations filed on Acceptability trials. A trial with sites in several states counts in each.

California 2 trials
Nevada 1 trials
Florida 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Acceptability page

5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acceptability condition card totals 5 registered trials; most-linked intervention Moringa Powder - High Dose; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.